VEGFA and neoplasm: To determine whether the observed tumor inhibition in DNP-immune mice treated with VEGF–DNP is FcR dependent, wild-type, and FcR-deficient C57BL/6 mice were vaccinated against DNP, challenged with MC38 tumor cells, and treated with VEGF–DNP.